Su, Hao
Tian, Mingle
Wang, Yongxue
Li, Yuan
Shan, Ying
Jin, Ying
Wang, Tao
Feng, Fengzhi
Funding for this research was provided by:
Beijing Xisike Clinical Oncology Research Foundation (Y-zai2022/zd-0088)
National Key Clinical Specialty Construction Project (U114000)
Article History
Received: 4 October 2025
Accepted: 15 February 2026
First Online: 19 February 2026
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Peking Union Medical College Hospital (approval number: I-24PJ2004) on October 7, 2024. The requirement for informed consent was waived due to its retrospective nature.
: Not applicable.
: The authors declare no competing interests.